3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
2
Peritoneal Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Colonic Neoplasms
2
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pleural Effusion, Malignant
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorder, Chronic, with Eosinophilia
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Carcinoma
1
Abdominal Neoplasms
1
Interventions
pembrolizumab
7
Nivolumab
2
Ipilimumab
2
Cyclophosphamide
2
Cisplatin
2
spartalizumab
1
regorafenib
1
rebastinib
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
aldesleukin
1
abemaciclib
1
Tomography, Optical Coherence
1
Talc
1
Tablets
1
Sirolimus
1
Radiofrequency Ablation
1
Pemetrexed
1
Paclitaxel
1
Mitomycin
1
Midazolam
1
Levoleucovorin
1
Leucovorin
1
Letrozole
1
LY3023414
1
Interleukin-2
1
Injections
1
Immunologic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Cytoreduction Surgical Procedures
×
Other solid neoplasm
×
Clear all
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled